Archive: 12/12/2018

No female mice? Scientists may still approve NIH grant

The good news: An increasing number of scientists are including female animals in their experimental designs and analyses for preclinical studies, as required by the National Institutes of Health (NIH) in January 2016, reports ...

Dec 12, 2018

High-dose antipsychotics place children at increased risk of unexpected death

Children and young adults without psychosis who are prescribed high-dose antipsychotic medications are at increased risk of unexpected death, despite the availability of other medications to treat their conditions, according ...

Dec 12, 2018

0

45

Researchers examine testosterone use to increase BMD in HIV-infected men

A new study has shown that HIV-infected men had lower median bone mineral density (BMD) scores at the hip compared to HIV-uninfected men, and all men who received testosterone had significantly greater BMD scores at the lumbar ...

Dec 12, 2018

2

2

Researchers find chronic rhinitis influences hospital readmissions for asthma and COPD patients

Patients hospitalized for either asthma or chronic obstructive pulmonary disease (COPD) have a higher risk of being readmitted for a hospital stay within 30 days of release if they also suffer from chronic rhinitis, according ...

Dec 12, 2018

0

4

Hearing loss is a risk factor for premature death

A new study links hearing loss with an increased risk for mortality before the age of 75 due to cardiovascular disease. Researchers at the Robert N. Butler Columbia Aging Center at Columbia University Mailman School of Public ...

Dec 12, 2018

New mouse model may speed identification of promising muscular dystrophy therapies

A Massachusetts General Hospital (MGH) research team has created a new mouse model of a common form of muscular dystrophy with the potential of rapidly distinguishing promising therapeutic drugs from those unlikely to be ...

Dec 12, 2018

0

31

Study evaluates efficacy and safety of pancreatic cancer treatment in complex patient care cases

Gemcitabine given in combination with nab-paclitaxel is the standard of care for patients with advanced pancreatic cancer. This practice, however, rests on data obtained from several recent clinical trials enrolling patients ...

Dec 12, 2018